DiaMedica Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Note 8 - Accrued Payable and Accrued Liabilities

12 Months Ended

Dec. 31, 2020

8.	Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following (in thousands):

	December 31, 2020		December 31, 2019
Trade and other payables	$	1,099	$	182
Accrued compensation		483		419
Accrued research and other professional fees		360		172
Accrued clinical study costs		13		433
Accrued taxes and other liabilities		8		52
Total accrued liabilities	$	1,963	$	1,258